Corpus Intelligence IC Memo — PATIENTS CHOICE MED CNT-SMITH CNTY 2026-04-26 08:24 UTC
IC Memo — PATIENTS CHOICE MED CNT-SMITH CNTY
Investment Committee Memorandum | MS | 19 beds | Grade D | EBITDA uplift $100K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PATIENTS CHOICE MED CNT-SMITH CNTY

CCN 250163 | SMITH, MS | 19 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

PATIENTS CHOICE MED CNT-SMITH CNTY is a 19-bed community hospital in SMITH, MS with $1.1M in net patient revenue and a -86.6% operating margin. The hospital serves a payer mix of 0.0% Medicare, 0.0% Medicaid, and 100.0% commercial.

Thesis: Turnaround. Our ML models identify $100K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -86.6% to -77.8% (+881bps).

Net Revenue HCRIS$1.1M
Current EBITDA COMPUTED$-984K
Operating Margin COMPUTED-86.6%
Occupancy HCRISnan%
Revenue / Bed COMPUTED$60K
Net-to-Gross HCRIS85.2%
Distress Probability MLnan%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
53
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of -86.6% places it below the state median. Among 53 size-comparable peers (10-38 beds), the median margin is -14.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (10-38), prioritizing same-state peers. 53 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PATIENTS CHOICE MED CNT-SMITH (Target)MS19$1.1M-86.6%
KINGS DAUGHTERS MEDICAL CENTERMS22$91.5M-8.4%
NORTH SUNFLOWER COUNTY HOSPITAMS25$70.1M-7.2%
MISSISSIPPI METHODIST REHAB CEMS31$68.1M-0.5%
NESHOBA COUNTY GENERAL HOSPITAMS38$47.6M-19.7%
MONROE REGIONAL HOSPITALMS25$45.6M0.9%
S.E. LACKEY MEMORIAL HOSPITALMS25$34.1M-2.1%
COVINGTON COUNTY HOSPITALMS25$33.7M-26.3%
PANOLA MEDICAL CENTERMS21$33.4M-21.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $100K (881bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$30K+265bp12mo
Net Collection Rate93.5%97.0%$24K+210bp18mo
Cost to Collect4.5%2.5%$23K+200bp12mo
A/R Days Reduction5200.0%3800.0%$14K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+85bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$30K
Net Collection Rate
$24K
Cost to Collect
$23K
A/R Days Reduction
$14K
Clean Claim Rate
$10K
Total EBITDA Uplift$100K
Current EBITDA$-984K
+ RCM Uplift+$100K
Pro Forma EBITDA$-884K
Current Margin-86.6%
Pro Forma Margin-77.8%
WC Released (1x)$44K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.5M$-5.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.5M$-6.5M0.00x-100.0%
Bull Case9.0x11.0x$-1.4M$-6.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.4M$-7.7M0.00x-100.0%
Bear Case11.0x10.0x$-1.7M$-5.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.7M$-6.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 53 hospitals with 10-38 beds
  • Same-state prioritization (n=54)
  • Comp margins: P25=-22.6% / P50=-14.9% / P75=-6.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.